Legend Biotech Corporation (FRA:9LB)
Germany · Delayed Price · Currency is EUR 25.00
0.00 (0.00%)
At close: Jun 26, 2026
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of €4.67 billion as of June 26, 2026. Its market cap has decreased by -20.43% in one year.
Market Cap
4.67B
Enterprise Value
4.28B
Revenue
987.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
€25.00
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has increased from 4.23B to 4.67B, an increase of 10.49%. That is a compound annual growth rate of 1.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 4.67B | 36.63% |
| Dec 31, 2025 | 3.42B | -40.69% |
| Dec 31, 2024 | 5.77B | -41.73% |
| Dec 29, 2023 | 9.90B | 26.55% |
| Dec 30, 2022 | 7.82B | 23.93% |
| Dec 31, 2021 | 6.31B | 106.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Darwin AG | 95.40M |
| 2invest AG | 44.96M |
| Biomark Diagnostics | 33.86M |
| Vidac Pharma Holding | 25.35M |
| co.don AG | 414.21K |
| Paion AG | 385.22K |
| bioXXmed AG | 222.93K |